S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Baker Bros Advisors/Q3 2024

Baker Bros Advisors

Period: Q3 2024 Β· Filed: 2024-11-14
View on SEC EDGAR β†—
AUM
$9.65B
Total portfolio value
Positions
93
Reported securities
Top Holding
ONC
24.6% $2.37B
QoQ Changes
+6 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2024-11-14) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
ONCBeiGene, Ltd.$2.37B24.59%$224.51$297.65+32.6%
24.6%
INCYIncyte Corporation$2.03B21.06%$66.10$116.86+76.8%
21.1%
ACADACADIA Pharmaceuticals Inc.$659.5M6.83%$15.38$25.97+68.9%
6.8%
SMMTSummit Therapeutics Inc.$534.9M5.54%$21.90$15.42-29.6%
5.5%
MDGLMadrigal Pharmaceuticals, Inc.$419.1M4.34%$212.22$528.10+148.8%
4.3%
RVMDRevolution Medicines, Inc.$343.3M3.56%$45.35$189.24+317.3%
3.6%
RYTMRhythm Pharmaceuticals, Inc.$335.2M3.47%$52.39$114.17+117.9%
3.5%
INSMInsmed Incorporated$322.4M3.34%$73.00$111.60+52.9%
3.3%
KYMRKymera Therapeutics, Inc.$283.8M2.94%$47.33$113.51+139.8%
2.9%
BCYCBicycle Therapeutics plc$212.7M2.20%$22.63$4.35-80.8%
2.2%
EWTXEdgewise Therapeutics, Inc.$155.9M1.62%$26.69$39.56+48.2%
1.6%
REPLReplimune Group, Inc.$121.1M1.25%$10.96$11.58+5.7%
1.3%
ALKSAlkermes plc$117.0M1.21%$27.99$54.58+95.0%
1.2%
DNLIDenali Therapeutics Inc.$108.7M1.13%$29.13$25.83-11.3%
1.1%
Insmed Incorporated$98.3M1.02%β€”β€”
1.0%
RAREUltragenyx Pharmaceutical Inc.$87.5M0.91%$55.55$33.47-39.8%
0.9%
NRIXNurix Therapeutics, Inc.$87.2M0.90%$22.47$23.97+6.7%
0.9%
TRDAEntrada Therapeutics, Inc.$77.8M0.81%$15.98$7.72-51.7%
0.8%
IMTXImmatics N.V.$73.5M0.76%$11.41$9.95-12.8%
0.8%
ABCLAbCellera Biologics Inc.$71.6M0.74%$2.60$8.11+211.9%
0.7%
KNSAKiniksa Pharmaceuticals International, plc$70.4M0.73%$24.99$64.53+158.2%
0.7%
IGMSIGM Biosciences, Inc.$67.7M0.70%β€”β€”
0.7%
ARGXargenx SE$60.7M0.63%$542.08$939.68+73.3%
0.6%
STOKStoke Therapeutics, Inc.$53.7M0.56%$12.29$32.70+166.1%
0.6%
IMCRImmunocore Holdings plc$47.2M0.49%$31.13$32.50+4.4%
0.5%
KODKodiak Sciences Inc.$45.2M0.47%$2.61$38.54+1376.6%
0.5%
SERASera Prognostics, Inc.$42.4M0.44%$7.80$2.00-74.4%
0.4%
CRSPCRISPR Therapeutics AG$39.6M0.41%$46.98$60.08+27.9%
0.4%
XENEXenon Pharmaceuticals Inc.$39.1M0.41%$39.37$60.96+54.8%
0.4%
IMVTImmunovant, Inc.$34.9M0.36%$28.51$38.79+36.1%
0.4%

Quarter-on-Quarter Activity

Q3 2024 vs. Q2 2024

New Positions (6)

TickerIssuerNotional
BCAXBicara Therapeutics Inc.$21.2M
ARVNArvinas, Inc.$10.0M
IONSIonis Pharmaceuticals, Inc.$8.9M
GPCRStructure Therapeutics Inc.$3.8M
WVEWave Life Sciences Ltd.$2.8M
ALGSAligos Therapeutics, Inc.$0.7M

Exited Positions (8)

TickerIssuerNotional
Insmed Incorporated$56.2M
CERECerevel Therapeutics Holdings, Inc.$27.9M
ATHAAthira Pharma, Inc.$8.4M
TLISTalis Biomedical Corporation$4.4M
ADAPYAdaptimmune Therapeutics plc$2.3M
SAGESage Therapeutics, Inc.$1.9M
ACHLAchilles Therapeutics plc$0.9M
ALGSAligos Therapeutics, Inc.$0.7M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
CRSPCRISPR Therapeutics AG$34.2M+743.1%+27.9%
SKYESkye Bioscience, Inc.$1.6M+186.9%
IMVTImmunovant, Inc.$22.7M+163.7%+36.1%
PRAXPraxis Precision Medicines, Inc.$13.2M+145.6%
CNTACentessa Pharmaceuticals plc$14.7M+123.4%
GBIOGeneration Bio Co.$1.4M+61.1%
INSMInsmed Incorporated$82.8M+23.5%+52.9%
XNCRXencor, Inc.$3.2M+22.9%

Trimmed (2)

TickerIssuerNotionalShares Ξ”
HOOKHOOKIPA Pharma Inc.$-1.3M-90.0%
NAMSNewAmsterdam Pharma Company N.V.$-0.3M-0.1%
← Back to Hedge Funds